{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:49:29Z","timestamp":1790812169396,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":2186,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","fertstert.org","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.fertnstert.2016.03.001","type":"journal-article","created":{"date-parts":[[2016,3,25]],"date-time":"2016-03-25T17:30:30Z","timestamp":1458927030000},"page":"1638-1648.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Magnetic nanoparticles as a new approach to improve the efficacy of gene therapy against differentiated human uterine fibroid cells and tumor-initiating stem cells"],"prefix":"10.1016","volume":"105","author":[{"given":"Shahinaz Mahmood","family":"Shalaby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa K.","family":"Khater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aymara Mas","family":"Perucho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara A.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inas","family":"Helwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Laknaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iryna","family":"Lebedyeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman A.","family":"Al-Hendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2016.03.001_bib1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1177\/1933719111432867","article-title":"Medical treatment of uterine leiomyoma","volume":"19","author":"Sabry","year":"2012","journal-title":"Reprod Sci"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(00)03622-9","article-title":"Uterine fibroids","volume":"357","author":"Stewart","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib3","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1210\/jcem-63-3-619","article-title":"Toward removing uterine fibroids without surgery: subcutaneous infusion of a luteinizing hormone-releasing hormone agonist commencing in the luteal phase","volume":"63","author":"Healy","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/107155760000700410","article-title":"Preclinical evidence for therapeutic efficacy of selective estrogen receptor modulators for uterine leiomyoma","volume":"7","author":"Walker","year":"2000","journal-title":"J Soc Gynecol Investig"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib5","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1126\/science.1112063","article-title":"Uterine fibroids: the elephant in the room","volume":"308","author":"Walker","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib6","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/oxfordjournals.humrep.a135748","article-title":"Effect of uterine leiomyomata on the results of in-vitro fertilization treatment","volume":"10","author":"Farhi","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib7","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0015-0282(98)00265-9","article-title":"Effect of intramural, subserosal, and submucosal uterine fibroids on the outcome of assisted reproductive technology treatment","volume":"70","author":"Eldar-Geva","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib8","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1093\/humrep\/16.11.2411","article-title":"A prospective controlled study of the effect of intramural uterine fibroids on the outcome of assisted conception","volume":"16","author":"Hart","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0015-0282(00)01714-3","article-title":"Impact of intramural leiomyomata in patients with a normal endometrial cavity on in\u00a0vitro fertilization-embryo transfer cycle outcome","volume":"75","author":"Surrey","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib10","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/ajcp\/94.4.435","article-title":"The frequency of uterine leiomyomas","volume":"94","author":"Cramer","year":"1990","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib11","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ajog.2015.04.028","article-title":"Appropriate indications and alternatives to hysterectomy for benign conditions","volume":"213","author":"Wertheim","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib12","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0015-0282(02)04538-7","article-title":"Ontario Uterine Fibroid Embolization Trial. Part 2. Uterine fibroid reduction and symptom relief after uterine artery embolization for fibroids","volume":"79","author":"Pron","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib13","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.bpobgyn.2007.07.010","article-title":"An evidence-based approach to hormonal therapies for premenopausal women with fibroids","volume":"22","author":"Lethaby","year":"2008","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib14","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/humupd\/dml015","article-title":"Gene therapy and uterine leiomyoma: a review","volume":"12","author":"Al-Hendy","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib15","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.fertnstert.2008.09.086","article-title":"Gene therapy targeting leiomyoma: adenovirus-mediated delivery of dominant-negative estrogen receptor gene shrinks uterine tumors in Eker rat model","volume":"93","author":"Hassan","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib16","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1093\/humrep\/det275","article-title":"Targeting adenoviral vectors for enhanced gene therapy of uterine leiomyomas","volume":"28","author":"Nair","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib17","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/humrep\/dem410","article-title":"Toward gene therapy of uterine fibroids: targeting modified adenovirus to human leiomyoma cells","volume":"23","author":"Hassan","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000209675","article-title":"Towards fibroid gene therapy: adenovirus-mediated delivery of herpes simplex virus 1 thymidine kinase gene\/ganciclovir shrinks uterine leiomyoma in the Eker rat model","volume":"68","author":"Hassan","year":"2009","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000353426","article-title":"Towards gene therapy of postoperative adhesions: fiber and transcriptional modifications enhance adenovirus targeting towards human adhesion cells","volume":"76","author":"Nair","year":"2013","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib20","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1182\/blood-2006-06-032524","article-title":"Adenovirus-induced thrombocytopenia: the role of von Willebrand factor and P-selectin in mediating accelerated platelet clearance","volume":"109","author":"Othman","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib21","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nm0596-545","article-title":"Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors","volume":"2","author":"Tripathy","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib22","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1089\/hum.1997.8.10-1275","article-title":"Immune responses to reporter proteins and high viral dose limit duration of expression with adenoviral vectors: comparison of E2a wild type and E2a deleted vectors","volume":"8","author":"Morral","year":"1997","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib23","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1006\/mthe.2001.0330","article-title":"Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors","volume":"3","author":"Schnell","year":"2001","journal-title":"Mol Ther"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib24","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ymgme.2003.08.016","article-title":"Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer","volume":"80","author":"Raper","year":"2003","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib25","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1126\/science.286.5448.2244","article-title":"Gene therapy death prompts review of adenovirus vector","volume":"286","author":"Marshall","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib26","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1210\/jc.2012-3647","article-title":"Overexpression of integrin-\u03b21 in leiomyoma promotes cell spreading and proliferation","volume":"98","author":"Chen","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib27","first-page":"3137","article-title":"Improved gene transfer into bladder cancer cells using adenovirus vector containing RGD motif","volume":"32","author":"Hiwasa","year":"2012","journal-title":"Anticancer Res"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib28","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1021\/mp100123t","article-title":"Boosting oncolytic adenovirus potency with magnetic nanoparticles and magnetic force","volume":"7","author":"Tresilwised","year":"2010","journal-title":"Mol Pharm"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib29","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/sj.gt.3301624","article-title":"Magnetofection: enhancing and targeting gene delivery by magnetic force in\u00a0vitro and in\u00a0vivo","volume":"9","author":"Scherer","year":"2002","journal-title":"Gene Ther"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib30","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.addr.2011.08.002","article-title":"Magnetically enhanced nucleic acid delivery: ten years of magnetofection\u2014progress and prospects","volume":"63","author":"Plank","year":"2011","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib31","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.fertnstert.2015.04.021","article-title":"Stro-1\/CD44 as putative human myometrial and fibroid stem cell markers","volume":"104","author":"Mas","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib32","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.fertnstert.2012.04.044","article-title":"Identification and characterization of the human leiomyoma side population as putative tumor-initiating cells","volume":"98","author":"Mas","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib33","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1073\/pnas.91.8.3054","article-title":"Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in\u00a0vivo","volume":"91","author":"Chen","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib34","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/mthe.2001.0446","article-title":"An adenovirus with enhanced infectivity mediates molecular chemotherapy of ovarian cancer cells and allows imaging of gene expression","volume":"4","author":"Hemminki","year":"2001","journal-title":"Mol Ther"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib35","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1471-0528.1991.tb13429.x","article-title":"Risk of recurrence after myomectomy","volume":"98","author":"Candiani","year":"1991","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib36","unstructured":"Stewart EA. Differentiating uterine leiomyomas (fibroids) from uterine sarcomas. UpToDate, February 29, 2016. Available at: http:\/\/www.uptodate.com\/contents\/differentiating-uterine-leiomyomas-fibroids-from-uterine-sarcomas. Last accessed April 4, 2016."},{"key":"10.1016\/j.fertnstert.2016.03.001_bib37","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.9734\/BJMMR\/2015\/15880","article-title":"A review of treatment options available for women with uterine fibroids","volume":"6","author":"Okeke","year":"2015","journal-title":"Br J Med Med Res"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib38","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ogc.2014.09.009","article-title":"Clinical management of leiomyoma","volume":"42","author":"Owen","year":"2015","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib39","doi-asserted-by":"crossref","first-page":"967568","DOI":"10.1155\/2015\/967568","article-title":"Fertility and symptom relief following robot-assisted laparoscopic myomectomy","volume":"2015","author":"Pitter","year":"2015","journal-title":"Obstet Gynecol Int"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib40","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/1933719115584449","article-title":"The mechanism and function of epigenetics in uterine leiomyoma development","volume":"23","author":"Yang","year":"2015","journal-title":"Reprod Sci"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib41","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.fertnstert.2014.04.051","article-title":"Current understanding of somatic stem cells in leiomyoma formation","volume":"102","author":"Mas","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib42","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000095627","article-title":"Gene therapy of uterine leiomyoma: adenovirus-mediated herpes simplex virus thymidine kinase\/ganciclovir treatment inhibits growth of human and rat leiomyoma cells in\u00a0vitro and in a nude mouse model","volume":"63","author":"Salama","year":"2007","journal-title":"Gynecol Obstet Investig"},{"issue":"Suppl 1","key":"10.1016\/j.fertnstert.2016.03.001_bib43","doi-asserted-by":"crossref","first-page":"S164","DOI":"10.1002\/jgm.496","article-title":"Adenoviral vectors for gene transfer and therapy","volume":"6","author":"Volpers","year":"2004","journal-title":"J Gene Med"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib44","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.ajog.2004.04.022","article-title":"Gene therapy of uterine leiomyomas: adenovirus-mediated expression of dominant negative estrogen receptor inhibits tumor growth in nude mice","volume":"191","author":"Al-Hendy","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib45","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1067\/mob.2000.104837","article-title":"Ovarian cancer gene therapy: repeated treatment with thymidine kinase in an adenovirus vector and ganciclovir improves survival in a novel immunocompetent murine model","volume":"182","author":"Al-Hendy","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib46","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1016\/j.ymthe.2005.06.262","article-title":"259. Uterine fibroids gene therapy: adenovirus-mediated herpes simplex virus thymidine kinase\/ganciclovir treatment inhibits growth of human and rat leiomyoma cells","volume":"11","author":"Al-Hendy","year":"2005","journal-title":"Mol Ther"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib47","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.fertnstert.2008.09.086","article-title":"Gene therapy targeting leiomyoma: adenovirus-mediated delivery of dominant-negative estrogen receptor gene shrinks uterine tumors in Eker rat model","volume":"93","author":"Hassan","year":"2010","journal-title":"Fertil steril"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib48","doi-asserted-by":"crossref","first-page":"9706","DOI":"10.1128\/JVI.72.12.9706-9713.1998","article-title":"An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism","volume":"72","author":"Dmitriev","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib49","doi-asserted-by":"crossref","first-page":"869269","DOI":"10.1155\/2014\/869269","article-title":"Drug delivery systems, CNS protection, and the blood brain barrier","volume":"2014","author":"Upadhyay","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib50","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/sj.cgt.7700541","article-title":"Adenoviral vectors: systemic delivery and tumor targeting","volume":"9","author":"Green","year":"2002","journal-title":"Cancer Gene Ther"},{"issue":"Suppl 1","key":"10.1016\/j.fertnstert.2016.03.001_bib51","first-page":"S75","article-title":"Use of magnetic nanoparticles and oscillating magnetic field for non-viral gene transfer into mouse cornea","volume":"385","author":"Ng","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib52","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1021\/acs.langmuir.5b01208","article-title":"Redox-sensitive polymer\/SPIO nanocomplexes for efficient magnetofection and MR imaging of human cancer cells","volume":"31","author":"Huang","year":"2015","journal-title":"Langmuir"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib53","doi-asserted-by":"crossref","first-page":"58345","DOI":"10.1039\/C5RA06562C","article-title":"Enhancement of nucleic acid delivery to hard-to-transfect human colorectal cancer cells by magnetofection at laminin coated substrates and promotion of the endosomal\/lysosomal escape","volume":"5","author":"Cerda","year":"2015","journal-title":"RSC Adv"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib54","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1081\/LPR-120017486","article-title":"Magnetofection: enhancing and targeting gene delivery with superparamagnetic nanoparticles and magnetic fields","volume":"13","author":"Plank","year":"2003","journal-title":"J Liposome Res"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib55","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1159\/000073901","article-title":"Magnetofection potentiates gene delivery to cultured endothelial cells","volume":"40","author":"Kr\u00f6tz","year":"2003","journal-title":"J Vasc Res"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib56","doi-asserted-by":"crossref","first-page":"6527","DOI":"10.1021\/nn2018717","article-title":"Magnetic nanoparticle-mediated gene transfer to oligodendrocyte precursor cell transplant populations is enhanced by magnetofection strategies","volume":"5","author":"Jenkins","year":"2011","journal-title":"ACS Nano"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib57","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1439-0442.2007.01002.x","article-title":"Intra-tumoral gene delivery of feIL-2, feIFN-gamma and feGM-CSF using magnetofection as a neoadjuvant treatment option for feline fibrosarcomas: a phase-I study","volume":"54","author":"Jahnke","year":"2007","journal-title":"J Vet Med A Physiol Pathol Clin Med"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib58","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.2349\/biij.6.2.e15","article-title":"Magnetic resonance-guided focused ultrasound surgery (MRgFUS) treatment for uterine fibroids","volume":"6","author":"Abdullah","year":"2010","journal-title":"Biomed Imaging Interv J"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib59","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1055\/s-0028-1102999","article-title":"Magnetic resonance-guided focused ultrasound for uterine fibroids","volume":"25","author":"Roberts","year":"2008","journal-title":"Semin Intervent Radiol"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib60","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1001\/jama.292.23.2826","article-title":"FDA approves ultrasound fibroid therapy","volume":"292","author":"Ringold","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib61","first-page":"6","article-title":"Treatment of uterine fibroid tumors in a nude mouse model using high-intensity focused ultrasound","volume":"183","author":"Vaezy","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib62","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ymthe.2006.03.023","article-title":"Adenoviral gene vector tethering to nanoparticle surfaces results in receptor-independent cell entry and increased transgene expression","volume":"14","author":"Chorny","year":"2006","journal-title":"Mol Ther"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib63","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s11095-011-0629-9","article-title":"Magnetic nanoparticles enhance adenovirus transduction in\u00a0vitro and in\u00a0vivo","volume":"29","author":"Sapet","year":"2012","journal-title":"Pharm Res"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib64","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1750-1326-5-17","article-title":"High-efficiency transfection of cultured primary motor neurons to study protein localization, trafficking, and function","volume":"5","author":"Fallini","year":"2010","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib65","first-page":"3825","article-title":"EGFR-targeted plasmonic magnetic nanoparticles suppress lung tumor growth by abrogating G2\/M cell-cycle arrest and inducing DNA damage","volume":"9","author":"Kuroda","year":"2014","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib66","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1095\/biolreprod.114.123794","article-title":"Tissue-specific stem cells in the myometrium and tumor-initiating cells in leiomyoma","volume":"91","author":"Ono","year":"2014","journal-title":"Biol Reprod"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib67","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/cgt.2012.41","article-title":"Intravenous administration of adenoviruses targeting transforming growth factor beta signaling inhibits established bone metastases in 4T1 mouse mammary tumor model in an immunocompetent syngeneic host","volume":"19","author":"Zhang","year":"2012","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.fertnstert.2016.03.001_bib68","doi-asserted-by":"crossref","first-page":"5725","DOI":"10.1021\/nn506928p","article-title":"Chitosan-decorated doxorubicin-encapsulated nanoparticle targets and eliminates tumor reinitiating cancer stem-like cells","volume":"9","author":"Rao","year":"2015","journal-title":"ACS Nano"},{"issue":"Suppl 1","key":"10.1016\/j.fertnstert.2016.03.001_bib69","first-page":"2","article-title":"Restoration of apoptosis in serous cancer stem cells sensitizes them to platinum therapy resulting in tumor eradication","volume":"137","author":"Janzen","year":"2015","journal-title":"Gynecol Oncol"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028216300012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028216300012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T01:12:51Z","timestamp":1666487571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028216300012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":69,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0015028216300012"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2016.03.001","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Magnetic nanoparticles as a new approach to improve the efficacy of gene therapy against differentiated human uterine fibroid cells and tumor-initiating stem cells","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2016.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a92016 Published by Elsevier Inc. on behalf of the American Society for Reproductive Medicine","name":"copyright","label":"Copyright"}]}}